首批生物制造中试平台名单发布 湖北4家平台入选数量居全国第一

Core Viewpoint - Hubei is accelerating its development into a national hub for the biomanufacturing industry, with significant investments and advancements in technology [1][4]. Group 1: Biomanufacturing Platforms - The Ministry of Industry and Information Technology (MIIT) announced the first batch of biomanufacturing pilot platforms, with 43 platforms selected, including four from Hubei, which ranks first nationally [2][4]. - The selected platforms are distributed across 25 provinces, with Hubei and Jiangsu each having four platforms, while Tianjin, Shanghai, Zhejiang, and Shandong have three [2]. Group 2: Investment and Research - During the 14th Five-Year Plan period, Hubei's total R&D investment in biomanufacturing exceeded 5.7 billion yuan, with 11,000 valid invention patents [1][5]. - Hubei has achieved significant breakthroughs in cutting-edge areas such as synthetic biology, protein engineering, and gene editing, with several key green biomanufacturing technologies reaching international advanced levels [5]. Group 3: Industry Development and Future Plans - By 2025, Hubei plans to implement 23 projects in critical areas such as enzyme preparations and industrial strains, aiming to break through 18 key technologies [5]. - The province is focusing on optimizing regional layout, accelerating the integration of science and industry, and expanding industrial scale to build a specialized service system [1][5].

首批生物制造中试平台名单发布 湖北4家平台入选数量居全国第一 - Reportify